These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8598469

  • 1. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM, Stevens JG.
    J Immunol; 1996 Jan 01; 156(1):246-55. PubMed ID: 8598469
    [Abstract] [Full Text] [Related]

  • 2. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A, Soleimanjahi H, Bamdad T, Soudi S, Arefeian E, Hashemi SM, Ebtekar M.
    Comp Immunol Microbiol Infect Dis; 2007 Jul 01; 30(4):197-210. PubMed ID: 17335902
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM, Dempsey D, Wolcott RM, Chervenak R, Jennings SR.
    J Immunol; 1999 Jul 15; 163(2):675-81. PubMed ID: 10395657
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL.
    Invest Ophthalmol Vis Sci; 1997 May 15; 38(6):1213-21. PubMed ID: 9152241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T cells in the uninjected eye after anterior chamber inoculation of herpes simplex virus type 1.
    Azumi A, Atherton SS.
    Invest Ophthalmol Vis Sci; 1998 Jan 15; 39(1):78-83. PubMed ID: 9430548
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S, Franchini M, Alber G, Ackermann M, Suter M.
    J Virol; 2001 Oct 15; 75(20):9596-600. PubMed ID: 11559791
    [Abstract] [Full Text] [Related]

  • 10. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
    Jamali A, Roostaee MH, Soleimanjahi H, Ghaderi Pakdel F, Bamdad T.
    Comp Immunol Microbiol Infect Dis; 2007 Mar 15; 30(2):71-80. PubMed ID: 17126902
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD, Chiou HC, Hull BE, Bigley NJ.
    Arch Virol; 2002 Sep 15; 147(9):1747-59. PubMed ID: 12209314
    [Abstract] [Full Text] [Related]

  • 14. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ, Parish ML, Spear PG.
    Virology; 1996 Jul 01; 221(1):1-13. PubMed ID: 8661409
    [Abstract] [Full Text] [Related]

  • 15. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP, Veress LA, Gebhardt BM, Carr DJ.
    Virology; 1997 Sep 29; 236(2):328-37. PubMed ID: 9325240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O.
    Gene Ther; 2003 Dec 29; 10(25):2059-66. PubMed ID: 14595378
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic potentials of glycoprotein C-negative syncytial mutants from rabbit T cells infected persistently with herpes simplex virus type 1.
    Ishida Y, Okabe T, Azukizawa Y, Isono T, Seto A.
    J Med Virol; 2005 May 29; 76(1):89-97. PubMed ID: 15779044
    [Abstract] [Full Text] [Related]

  • 19. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
    Rouse BT, Miller LS, Turtinen L, Moore RN.
    J Immunol; 1985 Feb 29; 134(2):926-30. PubMed ID: 2981270
    [Abstract] [Full Text] [Related]

  • 20. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL, Tumpey TM.
    Invest Ophthalmol Vis Sci; 1990 Oct 29; 31(10):1929-39. PubMed ID: 2170289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.